GBCC
Previous Meetings
GBCC Information
Archives
Previous Meetings
Photo Album
Announcement
What’s NEW
Previous Meetings (GBCC 2016)
※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.
Day 1, Apr 28 (Thu) Day 2, Apr 29 (Fri) Day 3, Apr 30 (Sat)
11:10-12:10
  • Plenary Lecture 1
      
  • Venue:  
    Halla Hall
12:10-13:10
  • Luncheon Symposium 1
      
  • Venue:  
    Halla Hall
  • Optimized Endocrine Treatment Strategy in ER+ Post Meno ABC Management
    Antonio Llombart Cussac (Medical Oncology Hospital Arnau de Vilanova in Valencia, Spain)Slide ViewVideo View
13:30-14:30
  • Plenary Lecture 2
      
  • Venue:  
    Halla Hall
  • Precision Medicine Based on Genomics in Breast Cancer
    Jorge Reis-Filho (Memorial Sloan Kettering Cancer Center, U.S.A.)Slide ViewVideo View
14:40-15:50
  • Symposium 1: 
    DCIS – What’s New?  
  • Venue:  
    Halla Hall
  • Molecular and Pathological Changes during Progression from in situ to Invasive Cancer
    So Yeon Park (Seoul National Univ. College of Medicine, Seoul National Univ. Bundang Hospital, Korea)Slide ViewVideo ViewAbstract
  • Personalized Treatment of DCIS
    Jeong Eon Lee (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
  • No Surgery for DCIS?
    Mehra Golshan (Dana Farber Cancer Institute, Brigham and Women’s Hospital, U.S.A.)Video ViewAbstract
  • Panel Discussion 1: 
    Circulating Tumor DNA - Myth or Reality?  
  • Venue:  
    Lotus Hall
  • Clinical Utility of CtDNA in Breast Cancer
    Jorge Reis-Filho (Memorial Sloan Kettering Cancer Center, U.S.A.)Slide ViewVideo View
  • Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial-mesenchymal Plasticity
    Seung Il Kim (Yonsei Univ. College of Medicine, Korea)Slide ViewVideo ViewAbstract
  • Oral Presentation 1
      
  • Venue:  
    Weolla Room
  • DETERMINATION OF ANTI-CANCER MECHANISMS OF GOSSYPETIN AND LUTEOLIN IN COMBINATION WITH CHEMOTHERAPEUTIC CYCLOPHOSPHOAMIDE ON MCF-7 HUMAN BREAST CANCER CELL LINES
    Elif Candan (Fatih Univ., Turkey)Slide ViewAbstract
  • DEVELOPMENT AND VALIDATION OF PERSONALIZED EX VIVO PLATFORM MIMICKING PATIENT HETEROGENEOUS TUMOR MICROENVIRONMENT TO ENABLE PERSONALIZED TREATMENT FOR BREAST CANCER
    Govind Babu K (Kidwai, India)Slide ViewAbstract
  • HI-PLEX FOR HIGH THROUGHPUT MUTATION SCREENING OF BRCA1, BRCA2, TP53, AND PALB2 IN BREAST AND OVARIAN CANCER PATIENTS
    Wei Xiong Wen (Cancer Research Malaysia, Malaysia)Slide ViewAbstract
  • DEAD-BOX RNA HELICASE DP103 AS A BIOMARKER FOR THERAPEUTIC RESPONSE TO DOCETAXEL
    Alan Prem Kumar (National Univ. of Singapore, Singapore)Slide ViewAbstract
  • THE BASIC FACTS OF KOREAN BREAST CANCER IN 2013: RESULTS OF A NATIONWIDE SURVEY AND BREAST CANCER REGISTRY DATABASE
    Sun Young Min (Kyung Hee Univ. School of Medicine, Korea)Slide ViewAbstract
  • IDENTIFICATION OF MOLECULES ASSOCIATED WITH TAMOXIFEN RESISTANCE THROUGH GENE EXPRESSION PROFILING OF TAMOXIFEN-RESISTANT BREAST CANCER CELLS
    Sang Hyeok Woo (Korea Institute of Radiological & Medical Sciences, Korea)Slide ViewAbstract
  • INHERITED PREDISPOSITION FOR BREAST CANCER IN DIVERSE HEREDITARY CANCER SYNDROMES: STRATEGIES FOR SYNDROME SPECIFIC GENETIC TESTING AND RISK MANAGEMENT
    Rajiv Sarin (Tata Memorial Centre, India)Slide ViewAbstract
  • EFFICACY AND SAFETY OF EVEROLIMUS AND EXEMESTANE IN PATIENTS WITH ADVANCED BREAST CANCER FROM ASIA AND AFRICA: ASIAN SUBSET RESULTS FROM THE PHASE 3B EVEREXES STUDY
    Young-Hyuck Im (Samsung Medical Center, Korea)Slide ViewAbstract
16:00-17:10
  • Symposium 2: 
    Optimal Breast Irradiation for Breast Cancer  
  • Venue:  
    Halla Hall
  • Current Perspectives on Radiation Therapy in Autologous and Prosthetic Breast Reconstruction
    Won Park (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
  • Regional Nodal Management in Breast Cancer: From Z11 to AMAROS
    Bruce Haffty (Rutgers Cancer Institute of New Jersey, U.S.A.)Slide ViewVideo ViewAbstract
  • Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
    Sung-Ja Ahn (Chonnam National Univ. Medical School, Korea)Slide ViewVideo ViewAbstract
  • Panel Discussion 2: 
    Biomarker Driven Clinical Trial Design in the Era of Precision Medicine in Breast Cancer  
  • Venue:  
    Lotus Hall
  • A Molecular Portrait of Asian Breast Cancer: Multi-omics and Immune Profiling of a Prospective Breast Cancer Cohort Enriched in Young, Premenopausal Patients
    Zhengyan Kan (Pfizer, Inc., U.S.A.)Slide ViewVideo ViewAbstract
  • Innovative Clinical Trial in the Era of Genomics
    Yeon Hee Park (Samsung Medical Center, Korea)Slide ViewVideo ViewAbstract
  • Education Session 1: 
    Current and Future Role of Neoadjuvant Therapy for Breast Cancer  
  • Venue:  
    Weolla Room
  • Surgical Issues in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
    Mehra Golshan (Dana Farber Cancer Institute, Brigham and Women’s Hospital, U.S.A.)Abstract
  • Neoadjuvant Therapy of Early Stage HER 2-positive Breast Cancer: Latest Evidence and Clinical Implications
    In Hae Park (National Cancer Center, Korea)Slide ViewAbstract
  • Neoadjuvant Endocrine Therapy in Breast Cancer
    Wonshik Han (Seoul National Univ. Hospital, Korea)Slide ViewAbstract


Back to Previous Meetings+



Global Breast Cancer Conference Secretariat

Partner I INTERCOM Convention Services, Inc. (Core PCO)

TOP